Symbols / BLFS Stock $20.76 -1.42% BioLife Solutions, Inc.

Healthcare • Medical Instruments & Supplies • United States • NCM
BLFS (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO Mr. Roderick de Greef
Exch · Country NCM · United States
Market Cap 1.01B
Enterprise Value 948.14M
Income -11.21M
Sales 101.66M
FCF (ttm) 6.39M
Book/sh 7.62
Cash/sh 1.66
Employees 155
Insider 10d —
IPO Nov 22, 1989
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 71.59
PEG 15.09
P/S 9.98
P/B 2.72
P/C —
EV/EBITDA 219.43
EV/Sales 9.33
Quick Ratio 5.15
Current Ratio 7.30
Debt/Eq 3.99
LT Debt/Eq —
EPS (ttm) -0.24
EPS next Y 0.29
EPS Growth —
Revenue Growth 24.70%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-06
Earnings (prior) 2026-05-07
ROA -0.09%
ROE -3.09%
ROIC —
Gross Margin 63.76%
Oper. Margin 0.10%
Profit Margin -2.91%
Shs Outstand 48.86M
Shs Float 41.64M
Insider Own 2.39%
Instit Own 106.17%
Short Float 11.62%
Short Ratio 9.88
Short Interest 3.63M
52W High 29.62
vs 52W High -29.91%
52W Low 17.86
vs 52W Low 16.24%
Beta 1.97
Impl. Vol. 93.36%
Rel Volume 0.88
Avg Volume 424.08K
Volume 375.00K
Target (mean) $32.30
Tgt Median $32.50
Tgt Low $30.00
Tgt High $34.00
# Analysts 10
Recom Strong_buy
Prev Close $21.06
Price $20.76
Change -1.42%
About

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction products, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; CryoCase cryo-compatible transparent rigid containers for closed-system fill and retrieval, and automated cell processing machines; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$32.30
Mean price target
2. Current target
$20.76
Latest analyst target
3. DCF / Fair value
$2.35
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$20.76
Low
$30.00
High
$34.00
Mean
$32.30

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-12-29 reit HC Wainwright & Co. Buy → Buy $32
2025-11-24 reit HC Wainwright & Co. Buy → Buy $32
2025-08-08 main HC Wainwright & Co. Buy → Buy $32
2025-05-13 reit HC Wainwright & Co. Buy → Buy $30
2025-03-06 main HC Wainwright & Co. Buy → Buy $30
2025-01-08 main Northland Capital Markets Outperform → Outperform $31
2024-12-19 reit Benchmark Buy → Buy $30
2024-12-13 main Keybanc Overweight → Overweight $33
2024-11-18 main HC Wainwright & Co. Buy → Buy $27
2024-11-13 main TD Cowen Buy → Buy $31
2024-11-13 main Craig-Hallum Buy → Buy $32
2024-09-30 init HC Wainwright & Co. — → Buy $29
2024-08-12 main Craig-Hallum Buy → Buy $30
2024-08-09 main Northland Capital Markets Outperform → Outperform $28
2024-07-17 main TD Cowen Buy → Buy $26
2024-05-13 up Benchmark Hold → Buy $25
2024-04-04 init Jefferies — → Buy $22
2023-08-10 main Craig-Hallum Buy → Buy $23
2023-08-09 main TD Cowen Outperform → Outperform $25
2023-08-09 main Lake Street Buy → Buy $25
News
RSS: Latest BLFS news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-23 FOSTER KAREN A Officer — 2,577 $19.17 $49,401
2026-03-09 FOSTER KAREN A Chief Operating Officer — 97,423 $20.00 $1,962,998
2026-03-03 WICHTERMAN TROY Chief Financial Officer — 588 $20.74 $12,195
2026-03-03 WERNER SEAN Chief Technology Officer — 111 $20.74 $2,302
2026-03-03 MATHEW ABY J Officer — 529 $20.74 $10,971
2026-03-03 AEBERSOLD SARAH Officer — 219 $20.74 $4,542
2026-03-03 BERARD TODD C.J. Officer — 353 $20.74 $7,321
2026-03-03 FOSTER KAREN A Officer — 418 $20.74 $8,669
2026-02-24 ELLINGSON RACHEL H. Director — 8,170 $0.00 $0
2026-02-24 HUNT ANTHONY JOHN Director — 8,170 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
96.21
+28.89%
74.65
+9.75%
68.02
-10.79%
76.24
Operating Revenue
96.21
+28.89%
74.65
+9.75%
68.02
-10.79%
76.24
Cost Of Revenue
34.10
+38.88%
24.55
-8.04%
26.70
-8.97%
29.33
Reconciled Cost Of Revenue
29.67
+83.69%
16.15
+4.65%
15.44
-8.38%
16.85
Gross Profit
62.12
+24.00%
50.10
+21.24%
41.32
-11.92%
46.91
Operating Expense
78.72
+44.25%
54.57
-10.12%
60.72
+5.43%
57.59
Research And Development
23.09
+385.94%
4.75
-13.85%
5.51
-36.40%
8.67
Selling General And Administration
55.37
+11.73%
49.56
-8.51%
54.17
+20.57%
44.93
Selling And Marketing Expense
9.85
+10.28%
8.93
-21.49%
11.38
-2.53%
11.67
General And Administrative Expense
45.52
+12.04%
40.63
-5.06%
42.79
+28.68%
33.26
Other Gand A
45.52
+12.04%
40.63
-5.06%
42.79
+28.68%
33.26
Total Expenses
112.82
+42.58%
79.12
-9.48%
87.41
+0.57%
86.92
Operating Income
-16.60
-270.83%
-4.48
+76.92%
-19.40
-81.68%
-10.68
Total Operating Income As Reported
-16.60
-270.83%
-4.48
+73.98%
-17.20
-190.48%
-5.92
EBITDA
-11.91
-384.78%
4.18
+158.90%
-7.10
-222.57%
5.79
Normalized EBITDA
-11.91
-244.28%
8.26
+157.30%
-14.41
-4289.24%
0.34
Reconciled Depreciation
4.69
-45.88%
8.66
-29.56%
12.29
-25.36%
16.47
EBIT
-16.60
-270.83%
-4.48
+76.92%
-19.40
-81.68%
-10.68
Total Unusual Items
0.00
+100.00%
-4.07
-155.75%
7.31
+34.07%
5.45
Total Unusual Items Excluding Goodwill
0.00
+100.00%
-4.07
-155.75%
7.31
+34.07%
5.45
Special Income Charges
0.00
0.00
-100.00%
7.31
+53.72%
4.75
Impairment Of Capital Assets
—
—
15.48
-85.97%
110.36
Restructuring And Mergern Acquisition
0.00
0.00
+100.00%
-7.31
-53.72%
-4.75
Net Income
-4.59
+77.23%
-20.18
+70.32%
-68.00
+51.36%
-139.81
Pretax Income
-12.08
-36.93%
-8.82
+27.80%
-12.22
-152.08%
-4.85
Net Non Operating Interest Income Expense
2.71
+453.26%
-0.77
+45.52%
-1.41
-395.07%
-0.28
Net Interest Income
2.71
+453.26%
-0.77
+45.52%
-1.41
-395.07%
-0.28
Other Income Expense
1.81
+150.70%
-3.58
-141.71%
8.58
+40.41%
6.11
Other Non Operating Income Expenses
1.81
+267.41%
0.49
-61.25%
1.27
+92.60%
0.66
Gain On Sale Of Security
—
-4.07
—
0.70
Tax Provision
0.05
+228.95%
-0.04
+40.63%
-0.06
+98.78%
-5.24
Tax Rate For Calcs
0.00
+5150.00%
0.00
-60.00%
0.00
-75.00%
0.00
Tax Effect Of Unusual Items
0.00
+100.00%
-0.02
-122.30%
0.07
-66.48%
0.22
Net Income Including Noncontrolling Interests
-4.59
+77.23%
-20.18
+70.32%
-68.00
+51.36%
-139.81
Net Income From Continuing Operation Net Minority Interest
-12.13
-38.08%
-8.79
+27.74%
-12.16
-3233.25%
0.39
Net Income From Continuing And Discontinued Operation
-4.59
+77.23%
-20.18
+70.32%
-68.00
+51.36%
-139.81
Net Income Continuous Operations
-12.13
-38.08%
-8.79
+27.74%
-12.16
-3233.25%
0.39
Net Income Discontinuous Operations
7.54
+166.10%
-11.40
+79.59%
-55.84
+60.17%
-140.19
Normalized Income
-12.13
-156.59%
-4.73
+75.62%
-19.39
-300.25%
-4.84
Net Income Common Stockholders
-4.59
+77.23%
-20.18
+70.32%
-68.00
+51.36%
-139.81
Otherunder Preferred Stock Dividend
—
—
—
0.00
Diluted EPS
—
-0.44
+71.61%
-1.55
+52.89%
-3.29
Basic EPS
—
-0.44
+71.61%
-1.55
+52.89%
-3.29
Basic Average Shares
—
46.07
+5.37%
43.72
+2.91%
42.48
Diluted Average Shares
—
46.07
+5.37%
43.72
+2.91%
42.48
Diluted NI Availto Com Stockholders
-4.59
+77.23%
-20.18
+70.32%
-68.00
+51.36%
-139.81
Average Dilution Earnings
—
—
—
0.00
Amortization
0.26
+0.00%
0.26
-74.52%
1.03
-74.14%
3.99
Amortization Of Intangibles Income Statement
0.26
+0.00%
0.26
-74.52%
1.03
-74.14%
3.99
Depreciation Amortization Depletion Income Statement
0.26
+0.00%
0.26
-74.52%
1.03
-74.14%
3.99
Depreciation And Amortization In Income Statement
0.26
+0.00%
0.26
-74.52%
1.03
-74.14%
3.99
Earnings From Equity Interest
—
—
—
—
Total Other Finance Cost
-2.71
-453.26%
0.77
-45.52%
1.41
+395.07%
0.28
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
405.88
+1.60%
399.49
-3.20%
412.71
-8.33%
450.23
Current Assets
136.56
-8.20%
148.76
+23.35%
120.60
-12.89%
138.45
Cash Cash Equivalents And Short Term Investments
88.93
-11.72%
100.74
+127.99%
44.18
-29.53%
62.70
Cash And Cash Equivalents
33.04
-63.91%
91.54
+228.14%
27.90
+43.48%
19.44
Other Short Term Investments
55.89
+507.62%
9.20
-43.53%
16.29
-62.35%
43.26
Receivables
7.95
-6.17%
8.48
+7.32%
7.90
-76.73%
33.94
Accounts Receivable
7.95
-6.17%
8.48
+7.32%
7.90
-76.73%
33.94
Gross Accounts Receivable
7.97
-7.57%
8.63
-9.19%
9.50
-72.60%
34.67
Allowance For Doubtful Accounts Receivable
-0.02
+85.53%
-0.15
+90.52%
-1.60
-116.91%
-0.74
Inventory
30.16
+3.94%
29.01
+6.81%
27.16
-22.18%
34.90
Raw Materials
10.56
-10.26%
11.77
-19.77%
14.67
-29.99%
20.95
Work In Process
6.37
+56.08%
4.08
+17.47%
3.48
-38.82%
5.68
Finished Goods
13.22
+0.46%
13.16
+45.92%
9.02
+9.03%
8.27
Prepaid Assets
—
—
—
—
Restricted Cash
—
—
0.03
+0.00%
0.03
Assets Held For Sale Current
0.00
-100.00%
4.58
-87.51%
36.69
—
Other Current Assets
9.53
+60.05%
5.95
+27.53%
4.67
-32.16%
6.88
Total Non Current Assets
269.32
+7.42%
250.73
-14.17%
292.11
-6.31%
311.78
Net PPE
22.18
+34.20%
16.53
+31.51%
12.57
-67.94%
39.20
Gross PPE
27.11
+31.08%
20.68
+22.91%
16.83
-65.21%
48.37
Accumulated Depreciation
-4.93
-18.66%
-4.16
+2.46%
-4.26
+53.52%
-9.17
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.27
-0.75%
0.27
-55.20%
0.60
-68.76%
1.91
Construction In Progress
11.27
+365.81%
2.42
-3.74%
2.51
-50.68%
5.09
Other Properties
12.07
-16.58%
14.47
+41.63%
10.22
-71.71%
36.12
Leases
3.51
-0.57%
3.53
+0.69%
3.50
-33.26%
5.25
Goodwill And Other Intangible Assets
212.84
-0.61%
214.15
-4.52%
224.30
-12.67%
256.83
Goodwill
208.59
+0.00%
208.59
-1.75%
212.30
-5.53%
224.74
Other Intangible Assets
4.26
-23.50%
5.57
-53.61%
12.00
-62.62%
32.09
Investments And Advances
31.25
+455.75%
5.62
+0.11%
5.62
-12.25%
6.40
Long Term Equity Investment
0.00
-100.00%
0.99
-80.37%
5.07
+0.00%
5.07
Non Current Prepaid Assets
—
—
0.27
-2.85%
0.28
Other Non Current Assets
3.05
-78.85%
14.42
-70.93%
49.63
+447.51%
9.06
Total Liabilities Net Minority Interest
34.00
-32.79%
50.58
-32.61%
75.05
-12.77%
86.04
Current Liabilities
22.98
-29.80%
32.73
-22.39%
42.18
-5.39%
44.58
Payables And Accrued Expenses
9.61
-34.99%
14.79
+9.08%
13.55
-42.62%
23.62
Payables
3.77
-50.41%
7.59
+9.50%
6.93
-66.16%
20.49
Accounts Payable
1.49
-55.77%
3.36
+48.02%
2.27
-85.23%
15.37
Current Accrued Expenses
5.85
-18.72%
7.19
+8.64%
6.62
+111.64%
3.13
Pensionand Other Post Retirement Benefit Plans Current
5.93
+22.89%
4.83
+119.85%
2.20
-56.77%
5.08
Total Tax Payable
2.28
-46.16%
4.23
-9.24%
4.66
-9.01%
5.13
Current Debt And Capital Lease Obligation
7.24
-41.62%
12.40
+63.81%
7.57
+56.68%
4.83
Current Debt
5.00
-54.34%
10.94
+74.11%
6.29
+246.47%
1.81
Other Current Borrowings
5.00
-54.34%
10.94
+74.11%
6.29
+246.47%
1.81
Current Capital Lease Obligation
2.24
+53.74%
1.46
+13.45%
1.29
-57.39%
3.02
Current Deferred Liabilities
0.20
+89.32%
0.10
+151.22%
0.04
-92.52%
0.55
Current Deferred Revenue
0.20
+89.32%
0.10
+151.22%
0.04
-92.52%
0.55
Other Current Liabilities
—
0.62
-96.73%
18.82
+759.57%
2.19
Total Non Current Liabilities Net Minority Interest
11.02
-38.26%
17.84
-45.72%
32.87
-20.71%
41.46
Liabilities Heldfor Sale Non Current
0.00
-100.00%
0.08
-98.80%
6.50
—
Long Term Debt And Capital Lease Obligation
10.66
-39.59%
17.64
-32.81%
26.26
-32.47%
38.88
Long Term Debt
—
5.00
-71.54%
17.56
-26.19%
23.79
Long Term Capital Lease Obligation
10.66
-15.72%
12.64
+45.43%
8.70
-42.37%
15.09
Non Current Deferred Liabilities
0.19
+52.42%
0.12
+8.77%
0.11
-54.40%
0.25
Non Current Deferred Taxes Liabilities
0.19
+52.42%
0.12
+8.77%
0.11
-54.40%
0.25
Other Non Current Liabilities
0.17
—
—
2.33
Stockholders Equity
371.89
+6.59%
348.91
+3.33%
337.66
-7.28%
364.19
Common Stock Equity
371.89
+6.59%
348.91
+3.33%
337.66
-7.28%
364.19
Capital Stock
0.05
+2.13%
0.05
+4.44%
0.04
+4.65%
0.04
Common Stock
0.05
+2.13%
0.05
+4.44%
0.04
+4.65%
0.04
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
48.20
+2.75%
46.91
+3.85%
45.17
+5.45%
42.83
Ordinary Shares Number
48.20
+2.75%
46.91
+3.85%
45.17
+5.45%
42.83
Additional Paid In Capital
711.40
+4.02%
683.94
+4.76%
652.88
+6.73%
611.74
Retained Earnings
-339.70
-1.37%
-335.10
-6.41%
-314.92
-27.54%
-246.91
Gains Losses Not Affecting Retained Earnings
0.13
+450.00%
0.02
+106.96%
-0.34
+49.19%
-0.68
Other Equity Adjustments
0.13
+450.00%
0.02
+106.96%
-0.34
+49.19%
-0.68
Total Equity Gross Minority Interest
371.89
+6.59%
348.91
+3.33%
337.66
-7.28%
364.19
Total Capitalization
371.89
+5.08%
353.91
-0.37%
355.22
-8.44%
387.98
Working Capital
113.58
-2.11%
116.03
+47.94%
78.43
-16.45%
93.87
Invested Capital
376.88
+3.30%
364.85
+0.92%
361.51
-7.26%
389.80
Total Debt
17.90
-40.43%
30.04
-11.18%
33.83
-22.62%
43.71
Net Debt
—
—
—
6.17
Capital Lease Obligations
12.90
-8.54%
14.10
+41.31%
9.98
-44.87%
18.11
Net Tangible Assets
159.04
+18.02%
134.76
+18.87%
113.36
+5.59%
107.36
Tangible Book Value
159.04
+18.02%
134.76
+18.87%
113.36
+5.59%
107.36
Available For Sale Securities
31.25
+575.24%
4.63
+744.53%
0.55
-58.86%
1.33
Current Provisions
—
—
7.86
-5.46%
8.31
Investmentin Financial Assets
31.25
+575.24%
4.63
+744.53%
0.55
-58.86%
1.33
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
20.11
+138.58%
8.43
+167.46%
-12.50
-47.24%
-8.49
Cash Flow From Continuing Operating Activities
20.11
+138.58%
8.43
+167.46%
-12.50
-47.24%
-8.49
Net Income From Continuing Operations
-4.59
+77.23%
-20.18
+70.32%
-68.00
+51.36%
-139.81
Depreciation Amortization Depletion
4.69
-45.88%
8.66
-29.56%
12.29
-25.36%
16.47
Depreciation
2.25
-56.34%
5.16
-27.47%
7.11
+5.00%
6.78
Amortization Cash Flow
2.43
-30.48%
3.50
-32.43%
5.18
-46.57%
9.70
Depreciation And Amortization
4.69
-45.88%
8.66
-29.56%
12.29
-25.36%
16.47
Amortization Of Intangibles
2.43
-30.48%
3.50
-32.43%
5.18
-46.57%
9.70
Other Non Cash Items
17.40
+4002.83%
0.42
+106.15%
-6.89
-535.70%
-1.08
Stock Based Compensation
22.99
-25.64%
30.92
-6.98%
33.24
+31.23%
25.33
Asset Impairment Charge
0.00
0.00
-100.00%
15.48
-85.97%
110.36
Deferred Tax
0.07
+201.56%
-0.06
-3.23%
-0.06
+98.82%
-5.24
Deferred Income Tax
0.07
+201.56%
-0.06
-3.23%
-0.06
+98.82%
-5.24
Operating Gains Losses
-9.80
+35.32%
-15.16
-1335.21%
1.23
-19.17%
1.52
Gain Loss On Investment Securities
—
—
—
—
Unrealized Gain Loss On Investment Securities
-0.98
-124.13%
4.07
0.00
+100.00%
-0.70
Gain Loss On Sale Of PPE
0.01
-92.86%
0.15
-75.67%
0.63
-15.03%
0.74
Change In Working Capital
-8.91
-4024.67%
0.23
-84.53%
1.47
+109.84%
-14.90
Change In Receivables
0.26
+109.11%
-2.90
-118.88%
15.35
+242.76%
-10.75
Changes In Account Receivables
0.26
+109.11%
-2.90
-118.88%
15.35
+242.76%
-10.75
Change In Inventory
-1.27
-262.36%
0.78
+109.13%
-8.55
-30.39%
-6.56
Change In Prepaid Assets
-3.04
-26.26%
-2.41
-1856.93%
0.14
+426.92%
0.03
Change In Payables And Accrued Expense
-5.13
-192.72%
5.54
+208.33%
-5.11
-237.16%
3.73
Change In Accrued Expense
-1.14
-117.64%
6.49
+223.93%
2.00
+12.03%
1.79
Change In Payable
-3.99
-321.44%
-0.95
+86.69%
-7.11
-466.70%
1.94
Change In Account Payable
-2.09
-8123.08%
0.03
+100.31%
-8.43
-2135.02%
0.41
Change In Other Working Capital
0.26
+202.33%
-0.26
-365.98%
0.10
+137.31%
-0.26
Change In Other Current Liabilities
0.01
+100.95%
-0.53
-16.30%
-0.45
+58.20%
-1.09
Investing Cash Flow
-71.54
-222.71%
58.30
+226.85%
17.84
+130.69%
-58.12
Cash Flow From Continuing Investing Activities
-71.54
-222.71%
58.30
+226.85%
17.84
+130.69%
-58.12
Net PPE Purchase And Sale
-9.48
-193.71%
-3.23
+49.43%
-6.38
+38.56%
-10.38
Purchase Of PPE
-9.48
-193.71%
-3.23
+49.43%
-6.38
+38.56%
-10.38
Sale Of PPE
—
—
0.00
0.00
Capital Expenditure
-19.70
-458.52%
-3.53
+44.73%
-6.38
+38.56%
-10.38
Net Investment Purchase And Sale
-74.47
-2225.89%
3.50
-87.95%
29.07
+165.78%
-44.20
Purchase Of Investment
-116.06
-530.26%
-18.41
+32.04%
-27.09
+48.99%
-53.12
Sale Of Investment
41.59
+89.77%
21.92
-60.98%
56.17
+529.70%
8.92
Net Business Purchase And Sale
23.52
-61.06%
60.39
0.00
0.00
Purchase Of Business
0.00
+100.00%
-13.04
0.00
0.00
Gain Loss On Sale Of Business
-10.32
+34.98%
-15.88
0.00
0.00
Net Intangibles Purchase And Sale
-10.22
-3307.00%
-0.30
0.00
0.00
Purchase Of Intangibles
-10.22
-3307.00%
-0.30
0.00
0.00
Net Other Investing Changes
-0.89
+57.16%
-2.07
+57.41%
-4.86
-37.33%
-3.54
Financing Cash Flow
-10.92
-61.05%
-6.78
-164.04%
10.59
-35.09%
16.32
Cash Flow From Continuing Financing Activities
-10.92
-61.05%
-6.78
-164.04%
10.59
-35.09%
16.32
Net Issuance Payments Of Debt
-10.00
-51.33%
-6.61
-1226.91%
-0.50
-102.79%
17.84
Issuance Of Debt
—
0.00
0.00
-100.00%
20.00
Repayment Of Debt
-10.00
-51.33%
-6.61
-1226.91%
-0.50
+76.99%
-2.16
Long Term Debt Issuance
—
0.00
0.00
-100.00%
20.00
Long Term Debt Payments
-10.00
-51.33%
-6.61
-1226.91%
-0.50
+76.99%
-2.16
Net Long Term Debt Issuance
-10.00
-51.33%
-6.61
-1226.91%
-0.50
-102.79%
17.84
Short Term Debt Issuance
—
—
0.00
0.00
Short Term Debt Payments
—
—
0.00
0.00
Net Short Term Debt Issuance
—
—
0.00
0.00
Net Common Stock Issuance
0.00
0.00
-100.00%
10.24
0.00
Proceeds From Stock Option Exercised
0.02
-91.09%
0.20
-60.16%
0.51
+56.97%
0.32
Net Other Financing Charges
-0.94
-149.87%
-0.38
-211.54%
0.34
+118.34%
-1.84
Changes In Cash
-62.35
-204.00%
59.95
+276.32%
15.93
+131.68%
-50.29
Effect Of Exchange Rate Changes
0.00
0.00
-100.00%
0.04
+132.41%
-0.11
Beginning Cash Position
95.39
+169.16%
35.44
+81.99%
19.47
-72.13%
69.87
End Cash Position
33.04
-65.36%
95.39
+169.16%
35.44
+81.99%
19.47
Free Cash Flow
0.42
-91.52%
4.90
+125.98%
-18.88
-0.03%
-18.87
Interest Paid Supplemental Data
0.76
-52.61%
1.61
-16.55%
1.93
+228.84%
0.59
Amortization Of Securities
-0.74
-55.27%
-0.47
+62.44%
-1.26
-182.33%
-0.45
Change In Income Tax Payable
-1.91
-95.79%
-0.97
-174.22%
1.31
-14.09%
1.53
Change In Tax Payable
-1.91
-95.79%
-0.97
-174.22%
1.31
-14.09%
1.53
Common Stock Issuance
0.00
0.00
-100.00%
10.24
0.00
Earnings Losses From Equity Investments
—
—
—
—
Issuance Of Capital Stock
0.00
0.00
-100.00%
10.24
0.00
Sale Of Business
23.52
-67.98%
73.43
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category